Rocket Lab Stock Slides 17% Over 5 Straight Down Days

A five-day slide has erased billions in market value, focusing attention on a story of rapid growth versus deep operating losses.

Rocket Lab (RKLB) stock has now moved lower for 5 consecutive trading days, posting a cumulative loss of 17%. That streak has erased about $8.7 billion from the company's market value, which now stands at about $43 billion.

For any investor holding the stock, a move of this size forces a fresh look at the relationship between the company's performance and its price.

RKLB Versus The S&P 500, Streak And Beyond

Here is how RKLB stock stacks up against the S&P 500 over the streak and the periods around it:

What Do The Fundamentals Say About This Price?

This decline is specific to the stock, not a reflection of the broader market. Over the same 5 trading days, the S&P 500 returned -1.2%. The numbers suggest the market may be weighing a business with a starkly mixed profile. On one hand, growth is exceptionally strong. Revenue over the last twelve months grew 52.5%, well ahead of the S&P 500 median revenue growth of 8.4%.

On the other hand, that growth is accompanied by significant losses. The company's operating margin over the last twelve months is -29.1%, compared to an S&P 500 median of 18.4%. RKLB also has negative trailing earnings, meaning it does not have a meaningful price-to-earnings multiple.

What Does A Five-Day Streak Actually Tell Me?

A streak is not a signal to buy or sell. It is simply information. It tells you that a stock has captured the market's attention and that momentum, in this case downward, has been persistent for a full trading week. The disciplined response is not to react to the momentum itself, but to use it as a prompt.

This is a moment to check the business against the price. The fundamental data here provides a starting point for that assessment, framing a clear trade-off between high growth and a current lack of profitability.

A slide like this always poses the same follow-up: which marked-down stocks are actually worth buying? Our Buy the Dip screen runs that test every day, flagging beaten-down names whose fundamentals still hold up.

And for anyone who would rather back the theme than one company's story, an aerospace & defense ETF like MISL holds the sector rather than this one name. It is still a concentrated bet on that one theme, though, which is exactly the gap the portfolio below closes.

Falling Prices Test Conviction. Rules Do Not Flinch

A losing streak forces a choice on every holder: sell into weakness, average down, or freeze. All three are emotional answers to what should be an analytical question, and emotions priced at market open are expensive.

The Trefis High Quality (HQ) Portfolio takes the emotion out: about 30 quality businesses screened for the fundamentals that survive bad stretches, held and rebalanced by rules. It has a track record of outpacing a benchmark that combines the three major indices - the S&P 500, S&P Mid-cap, and Russell 2000. Let the rules do the heavy lifting for you.